Overview

Food Effect Study With BMS-955176

Status:
Completed

Trial end date:
2016-08-15

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the impact of a light meal, a standard meal, and a high fat meal on the PK of BMS-955176 MC tablet at a dose of 180 mg, relative to fasted conditions.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb
ViiV Healthcare

Collaborator:

GlaxoSmithKline

Treatments:

BMS-955176